Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stem cell factor receptor, c-Kit (CD117), is a type III receptor tyrosine kinase activated by stem cell factor (SCF). It plays crucial roles in hematopoiesis, melanogenesis, gametogenesis, and mast cell development. Dysregulation, particularly activating mutations, is implicated in various cancers, including GISTs and leukemia. Therapeutic targeting involves small-molecule tyrosine kinase inhibitors like imatinib, sunitinib, and sorafenib.
Tyrosine kinase inhibition
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stem Cell Factor Receptor c-Kit (c-Kit).